These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16258322)

  • 1. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.
    Ellis MW; Lewis JS
    Curr Opin Infect Dis; 2005 Dec; 18(6):496-501. PubMed ID: 16258322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
    LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Loffler CA; Macdougall C
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Chambers HF
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM; Quinones-Nazario G; Lewis JS
    Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
    Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
    Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CA-MRSA].
    Iwata K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():436-40. PubMed ID: 17455658
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial agents in treatment of MRSA infections.
    Johnson MD; Decker CF
    Dis Mon; 2008 Dec; 54(12):793-800. PubMed ID: 18996282
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF; Frank AL
    Curr Opin Infect Dis; 2003 Jun; 16(3):265-9. PubMed ID: 12821819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
    Sabol KE; Echevarria KL; Lewis JS
    Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?
    Wunderink RG
    Infect Dis Clin North Am; 2013 Mar; 27(1):177-88. PubMed ID: 23398873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW; Wojda B
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections.
    Johnson JR
    Clin Infect Dis; 2003 Jan; 36(2):236-7. PubMed ID: 12522761
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.
    Lobo LJ; Reed KD; Wunderink RG
    Chest; 2010 Jul; 138(1):130-6. PubMed ID: 20173050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.